Sp930
PRESENTATION OF IMMUNOLOGY, MICROBIOLOGY & INFLAMMATORY BOWEL DISEASES (IMIBD) RESEARCH MENTOR AWARD: JEAN-FREDERIC COLOMBEL, MD
Date
May 20, 2024
Explore related products in the following collection:
Presenters
ucsf
Massachusetts General Hospital
Icahn School of Medicine at Mount Sinai
Tracks
Related Products
EARLY LIFE EXPOSURE TO AGRICULTURE AND BIODIVERSITY INFLUENCES CROHN’S DISEASE RISK IN A POPULATION-BASED COHORT STUDY
Specific pollutants and environmental exposures are implicated in modulating inflammatory bowel disease (IBD) risk. Crohn’s disease (CD) clustering has been reported in agricultural areas…
SIMPLE ENDOSCOPIC SCORE FOR CROHN’S DISEASE (SES-CD) ≥ 7 PREDICTS DISEASE PROGRESSION IN PATIENTS WITH MILD CD
Approximately 20-30% of individuals with Crohn's disease (CD) experience a relatively mild disease course without progression. However, there is no widely accepted objective definition of mild CD. We aimed to identify endoscopic severity cut-offs that can be used to define mild non-progressive CD…
DISEASE CLEARANCE AFTER 16 WEEKS OF TREATMENT WITH VEDOLIZUMAB IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: AN INTERIM ANALYSIS FROM THE VERDICT TRIAL
BACKGROUND: Disease clearance in ulcerative colitis (UC) is defined as concurrent achievement of clinical, endoscopic, and histologic remission…
NATURAL HISTORY OF PRESUMED ISOLATED CROHN'S DISEASE PERIANAL FISTULA
Approximately 20% of patients with Crohn’s disease (CD) have perianal fistulizing CD, which are most often complex perianal fistula (PAF). Studies have shown that 4-5% of patients with CD present with PAF without luminal disease, termed isolated perianal CD (iPCD)…
